The latest closing stock price for Kiniksa Pharmaceuticals as of February 21, 2025 is 20.02.
An investor who bought $1,000 worth of Kiniksa Pharmaceuticals stock at the IPO in 2018 would have $28 today, roughly 0 times their original investment - a 0.40% compound annual growth rate over 7 years.
The all-time high Kiniksa Pharmaceuticals stock closing price was 30.93 on September 20, 2018.
The Kiniksa Pharmaceuticals 52-week high stock price is 28.15, which is 40.6% above the current share price.
The Kiniksa Pharmaceuticals 52-week low stock price is 16.56, which is 17.3% below the current share price.
The average Kiniksa Pharmaceuticals stock price for the last 52 weeks is 21.50.
An investor who bought $1,000 worth of Kiniksa Pharmaceuticals stock at the IPO in 2018 would have $28 today, roughly 0 times their original investment - a 0.40% compound annual growth rate over 7 years.
The all-time high Kiniksa Pharmaceuticals stock closing price was 30.93 on September 20, 2018.
The Kiniksa Pharmaceuticals 52-week high stock price is 28.15, which is 40.6% above the current share price.
The Kiniksa Pharmaceuticals 52-week low stock price is 16.56, which is 17.3% below the current share price.
The average Kiniksa Pharmaceuticals stock price for the last 52 weeks is 21.50.